| Report ID | 275980 |
| Drug Identification Number | 02084287 |
| Brand name | NEURONTIN |
| Common or Proper name | GABAPENTIN |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | GABAPENTIN |
| Strength(s) | 400MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 100BTL |
| Anatomical Therapeutical Chemical (ATC) code | N02BF |
| Anatomical Therapeutical Chemical (ATC) description | |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | 2026-02-22 |
| Actual start date | 2026-02-02 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-02-10 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v11 | 2026-02-10 | French | Compare |
| v10 | 2026-02-10 | English | Compare |
| v9 | 2026-02-03 | French | Compare |
| v8 | 2026-02-03 | French | Compare |
| v7 | 2026-02-03 | English | Compare |
| v6 | 2026-01-26 | French | Compare |
| v5 | 2026-01-26 | English | Compare |
| v4 | 2026-01-19 | French | Compare |
| v3 | 2026-01-19 | English | Compare |
| v2 | 2026-01-13 | French | Compare |
| v1 | 2026-01-13 | English | Compare |
Showing 1 to 11 of 11